ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2974

An Outcome Survey of 100 Patients with Cerebral Venous Sinus Thrombosis Due to Behcet’s Syndrome Followed up at a Single, Dedicated Center

Enes Ali Kurt1, Naci Kocer2, Yesim Ozguler1, Didar Ucar3, Ugur Uygunoglu4, Civan Islak5, Sebahattin Saip4, Melike Melikoglu1, Vedat Hamuryudan1, Yilmaz Ozyazgan3, Sebahattin Yurdakul1, Aksel Siva4, Hasan Yazici1 and Emire Seyahi1, 1Istanbul University, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey, 2Department of Neuroradiology, Istanbul University, Cerrahpasa Medical Faculty, Department of Neuroradiology, Istanbul, Turkey, 3Ophthalmology, Istanbul University, Cerrahpasa Medical Faculty, Department of Ophthalmology, Istanbul, Turkey, 4Department of Neurology, Istanbul University, Cerrahpasa Medical Faculty, Department of Neurology, Istanbul, Turkey, 5Department of Neuroradiology, Istanbul University, Cerrahpasa Medical Faculty, Istanbul, Turkey

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Behcet's syndrome and thrombosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 15, 2016

Title: Vasculitis - Poster III: Rarer Vasculitides

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:   Behçet’s syndrome (BS) is a well-recognized cause of cerebral venous sinus thrombosis (CVST). We assessed the outcome of a large cohort of patients with CVST due to BS attending a single dedicated center.

Methods:   We identified 100 (81 M/19 F) patients with BS who were diagnosed as having CVST. All contacted were called back to the outpatient clinic for a clinical, neurological and ophthalmological examination and cranial MRI /MR venography.

Results:   Results: The mean age of the patients at the onset of the symptoms was 28 ± 10 years. A total of 48 patients developed CVST before or at the onset of ISG fulfillment, while 52 developed CVST after a median 3 [2-8] years of ISG fulfillment. Superior sagittal (n=47) and transverse sinuses (n=46) were most commonly involved followed by sigmoid sinus (n= 26) and jugular vein thrombosis (n= 15). A total of 59 (53 M/ 6 F) patients had vascular involvement in addition to CVST: these were deep vein thrombosis of the lower extremities (n= 47), pulmonary artery involvement (n = 17), Budd-Chiari syndrome (n= 9), vena cava superior thrombosis (n= 6) and major arterial disease (n=3). In about half (32/59), CVST preceded any type of additional vascular involvement. Apart from vascular involvement, eye involvement was seen in 37 patients, parenchymal CNS involvement in 8 (all later than CVST) and gastrointestinal involvement in 5. Seven patients (all male) had died, due to causes unrelated with CVST. By the end of the study (December 2015), all remaining 87 patients were alive and contacted with a median follow-up time of 11 [6-15] years. Only 6 patients had a relapsing CVST course. Information about medical treatment was present in detail in 87 patients of whom 75 received short courses of glucocorticoids with (n=12) or without anti-coagulants. A total of 81 patients received immunosuppressive agents, most commonly azathioprine. Four patients underwent lumbo-peritoneal shunting surgery (1 was successful) and 1 with arterio-venous fistula underwent vascular embolization. By the end of December 2015, a total of 50 patients were re-evaluated at the clinic. None had of symptoms of intracranial hypertension. Ophthalmological examination showed that 17 patients had complications such as bilateral optic atrophy (n= 3), bilateral papilledema (n= 5), bilateral optic disc pallor (n=4) and fibrotic scars around optic disc (n= 5). Sensorineural type hearing loss was detected in 4 patients. Neurological examination was found to be normal among 43 patients with isolated CSVT, whereas abnormal in the remaining 7 patients with concomitant parenchymal CNS involvement. Cranial MR/MR venographies at the end of follow-up, were abnormal in 36 patients showing occlusion/ irregularity/ hypoplasia or collaterals in the sagittal (n=19) or transverse sinus (n=17). In the remaining 14, MR venographies were normal.

Conclusion:   CVST due to BS is closely associated with vascular involvement in the body and may be considered as a risk factor for future vascular involvement. CVST relapses are rare; however, the course is not uneventful: visual acuity or field may be impaired totally or partially because of optic disc atrophy; in addition hearing deficits may occur.  


Disclosure: E. A. Kurt, None; N. Kocer, None; Y. Ozguler, None; D. Ucar, None; U. Uygunoglu, None; C. Islak, None; S. Saip, None; M. Melikoglu, None; V. Hamuryudan, None; Y. Ozyazgan, None; S. Yurdakul, None; A. Siva, None; H. Yazici, None; E. Seyahi, None.

To cite this abstract in AMA style:

Kurt EA, Kocer N, Ozguler Y, Ucar D, Uygunoglu U, Islak C, Saip S, Melikoglu M, Hamuryudan V, Ozyazgan Y, Yurdakul S, Siva A, Yazici H, Seyahi E. An Outcome Survey of 100 Patients with Cerebral Venous Sinus Thrombosis Due to Behcet’s Syndrome Followed up at a Single, Dedicated Center [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/an-outcome-survey-of-100-patients-with-cerebral-venous-sinus-thrombosis-due-to-behcets-syndrome-followed-up-at-a-single-dedicated-center/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/an-outcome-survey-of-100-patients-with-cerebral-venous-sinus-thrombosis-due-to-behcets-syndrome-followed-up-at-a-single-dedicated-center/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology